Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Jiangsu Chinagreen Biological Technology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥13.18 |
52 Week High | CN¥24.67 |
52 Week Low | CN¥9.27 |
Beta | 0.72 |
1 Month Change | -4.28% |
3 Month Change | 0.61% |
1 Year Change | -43.43% |
3 Year Change | -53.75% |
5 Year Change | n/a |
Change since IPO | -68.57% |
Recent News & Updates
Shareholder Returns
300970 | CN Food | CN Market | |
---|---|---|---|
7D | 9.6% | 1.8% | 4.2% |
1Y | -43.4% | -18.7% | -13.2% |
Return vs Industry: 300970 underperformed the CN Food industry which returned -18.7% over the past year.
Return vs Market: 300970 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
300970 volatility | |
---|---|
300970 Average Weekly Movement | 10.2% |
Food Industry Average Movement | 6.9% |
Market Average Movement | 8.7% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300970's share price has been volatile over the past 3 months.
Volatility Over Time: 300970's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 2,197 | Yangchao Yu | www.hualvbio.com |
Jiangsu Hualv Biological Technology Co.,Ltd. engages in the research, development, production, and sale of edible fungi in China. It offers Flammulina velutipes, and Shinji mushrooms, including white jade and crab-flavored mushrooms; and maitake, velvet, and other edible mushrooms.
Jiangsu Chinagreen Biological Technology Co.,Ltd. Fundamentals Summary
300970 fundamental statistics | |
---|---|
Market cap | CN¥1.55b |
Earnings (TTM) | -CN¥97.99m |
Revenue (TTM) | CN¥920.56m |
1.7x
P/S Ratio-15.9x
P/E RatioIs 300970 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300970 income statement (TTM) | |
---|---|
Revenue | CN¥920.56m |
Cost of Revenue | CN¥909.22m |
Gross Profit | CN¥11.33m |
Other Expenses | CN¥109.32m |
Earnings | -CN¥97.99m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.83 |
Gross Margin | 1.23% |
Net Profit Margin | -10.64% |
Debt/Equity Ratio | 14.9% |
How did 300970 perform over the long term?
See historical performance and comparison